Lupin ( Lupin)

Primary tabs

Lupin's picture

Management

Contact Address

About Lupin

The company was named after the Lupin flower because of the inherent qualities of the flower and what it personifies and stands for. The Lupin flower is known to nourish the land, the very soil it grows in. The Lupin flower is also known to be tolerant of infertile soils and capable of pioneering change in barren and poor climes. The Lupin flower and bean pods have also long been used as food and sources of nourishment, thus protecting and nurturing life.

Lupin press release, blog etc

Tue, 05/20/2025 - 20:09 Mumbai, Delhi, May 20, 2025 : Global pharma major Lupin Limited (Lupin) announced today its plan to use Honeywells Solstice Air (HFO-1234ze cGMP) propellant to transform respiratory care through the development of next-generation inhalers. Designed for pa
Fri, 05/16/2025 - 09:40 Mumbai, Naples, May 15, 2025: Global pharma major Lupin Limited (Lupin) announced the appointment of Punita Lal as an Additional Director (Non-Executive, Independent) to its Board of Directors.
Thu, 05/08/2025 - 22:03 Mumbai, Naples, May 8, 2025: Global pharma major Lupin Limited (Lupin) today announced that it has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for
Wed, 05/07/2025 - 21:49 Mumbai, Naples, May 7, 2025: Global pharma major Lupin Limited (Lupin) today announced that it has launched
Wed, 04/23/2025 - 19:34 Mumbai, India, April 23, 2025: Lupin Diagnostics Limited (LDL), a wholly owned subsidiary of g lobal pharma major Lupin Limited (Lupin) has achieved 100% NABL (National Accreditation Board for Testing and Calibration Laboratories) accreditation across all
Thu, 04/03/2025 - 07:03 Mumbai/Slough, Berkshire, United Kingdom, April 2, 2025: Lupin Healthcare (UK) Limited, the wholly owned subsidiary of global pharma major Lupin Limited (Lupin) announced today the acquisition of Renascience Pharma Limited (Renascience), a UK-based pharma
Thu, 03/20/2025 - 18:29 Mumbai, March 20, 2025 : Global pharma major Lupin Limited (Lupin) today announced that it has been awarded Silver Medal by EcoVadis for its outstanding sustainability management practices in areas such as Environment, Labor and Human Rights, Ethics and S
Wed, 02/19/2025 - 05:57 Mumbai, February 19, 2025 : Global pharma major Lupin Limited (Lupin) today announced that it has received an A- leadership rating from CDP for its outstanding performance in climate change and water security. This rating reflects Lupins leadership in env
Tue, 01/28/2025 - 17:51 Enables expanded access to the only EU-approved treatment for myotonia symptomsin adults with non-dystrophic myotonic disorders
Tue, 01/28/2025 - 17:51 Lupin Receives Approval from U.S. FDA for Ipratropium Bromide Nasal Solution (Nasal Spray), 0.06%
Sun, 01/12/2025 - 01:52 Lupin Receives Tentative Approval from U.S. FDA for Ivacaftor Oral Granules
Sat, 11/23/2024 - 09:41 Lupin and NAPCON Hosts a Walkathon A Step Towards HealThy Lungs for COPD Awareness
Sat, 08/24/2024 - 13:09 Mr. Nilesh Gupta, Managing Director, Lupin said, Weare committed to providing affordable and high-quality treatment to our patients. The Health Canada approval for Armlupeg strengthens our ability to support Canadian patients with this mainstay treatment.
Mon, 08/05/2024 - 21:27 India, USA, Europe, Russia, August 05, 2024: Global Pharma major Lupin Limited (Lupin) today announced the successful completion of a global Phase 3 clinical study of LUBT010, its biosimilar candidate to Lucentis. The study has achieved its primary endpoi
Sun, 12/04/2022 - 20:51 Lupin Launches Rufinamide Tablets USP in the United States
Mon, 11/14/2022 - 07:54 Ben Ellis, General Manager Lupin Healthcare UK.
Tue, 11/08/2022 - 13:54 Lupin Receives Tentative Approval from U.S. FDA for Doxycycline Capsules
Thu, 10/20/2022 - 03:21 Lupin Launches Paliperidone Extended-Release Tablets in the United States